scholarly journals Oxidative hotspots on actin promote skeletal muscle weakness in rheumatoid arthritis

JCI Insight ◽  
2019 ◽  
Vol 4 (9) ◽  
Author(s):  
Maarten M. Steinz ◽  
Malin Persson ◽  
Bejan Aresh ◽  
Karl Olsson ◽  
Arthur J. Cheng ◽  
...  
2018 ◽  
Vol 128 ◽  
pp. S106
Author(s):  
Maarten Steinz ◽  
Malin Persson ◽  
Bejan Aresh ◽  
Arthur Cheng ◽  
Emma Ahlstrand ◽  
...  

2020 ◽  
Vol 134 (21) ◽  
pp. 2835-2850
Author(s):  
Maarten M. Steinz ◽  
Estela Santos-Alves ◽  
Johanna T. Lanner

Abstract Rheumatoid arthritis (RA) is a chronic inflammatory disease characterized by synovitis and the presence of serum autoantibodies. In addition, skeletal muscle weakness is a common comorbidity that contributes to inability to work and reduced quality of life. Loss in muscle mass cannot alone account for the muscle weakness induced by RA, but instead intramuscular dysfunction appears as a critical factor underlying the decreased force generating capacity for patients afflicted by arthritis. Oxidative stress and associated oxidative post-translational modifications have been shown to contribute to RA-induced muscle weakness in animal models of arthritis and patients with RA. However, it is still unclear how and which sources of reactive oxygen and nitrogen species (ROS/RNS) that are involved in the oxidative stress that drives the progression toward decreased muscle function in RA. Nevertheless, mitochondria, NADPH oxidases (NOX), nitric oxide synthases (NOS) and phospholipases (PLA) have all been associated with increased ROS/RNS production in RA-induced muscle weakness. In this review, we aim to cover potential ROS sources and underlying mechanisms of oxidative stress and loss of force production in RA. We also addressed the use of antioxidants and exercise as potential tools to counteract oxidative stress and skeletal muscle weakness.


2019 ◽  
Vol 127 (1) ◽  
pp. 71-80 ◽  
Author(s):  
Koichi Himori ◽  
Daisuke Tatebayashi ◽  
Yuki Ashida ◽  
Takashi Yamada

Patients with rheumatoid arthritis (RA) frequently suffer from muscle weakness. We examined whether eccentric training prevents skeletal muscle weakness in adjuvant-induced arthritis (AIA) rat, a widely used animal model for RA. AIA was induced in the knees of Wistar rats by injection of complete Freund’s adjuvant. To induce eccentric contractions (ECCs), neuromuscular electrical stimulation (45 V) was applied to the plantar flexor muscles simultaneously with forced dorsiflexion of the ankle joint (0–40°) and was given every 6 s. ECC exercise was applied every other day for a total of 11 sessions and consisted of 4 sets of 5 contractions. There was a significant reduction in in vitro maximum Ca2+-activated force in skinned fibers in gastrocnemius muscle from AIA rats. These changes were associated with reduced expression levels of contractile proteins (i.e., myosin and actin), increased levels of inflammation redox stress-related biomarkers (i.e., TNF-α, malondialdehyde-protein adducts, NADPH oxidase 2, and neuronal nitric oxide synthase), and autolyzed active calpain-1 in AIA muscles. ECC training markedly enhanced the steady-state levels of αB-crystallin, a small heat shock protein, and its binding to the myofibrils and prevented the AIA-induced myofibrillar dysfunction, reduction in contractile proteins, and inflammation-oxidative stress insults. Our findings demonstrate that ECC training preserves myofibrillar function without muscle damage in AIA rats, which is at least partially attributable to the protective effect of αB-crystallin on the myofibrils against oxidative stress-mediated protein degeneration. Thus ECC training can be a safe and effective intervention, counteracting the loss of muscle strength in RA patients. NEW & NOTEWORTHY Eccentric contractions (ECCs) are regarded as an effective way to increase muscle strength. No studies, however, assess safety and effectiveness of ECC training on muscle weakness associated with rheumatoid arthritis. Here, we used adjuvant-induced arthritis (AIA) rats to demonstrate that ECC training prevents intrinsic contractile dysfunction without muscle damage in AIA rats, which may be attributed to the protective effect of αB-crystallin on the myofibrils against inflammation-oxidative stress insults.


Bone ◽  
2021 ◽  
pp. 116029
Author(s):  
Taro Fujimaki ◽  
Takashi Ando ◽  
Takanori Hata ◽  
Yoshihiro Takayama ◽  
Tetsuro Ohba ◽  
...  

2020 ◽  
Vol 10 (1) ◽  
Author(s):  
Jeffrey Y. Huang ◽  
Shih-Hsin Kan ◽  
Emilie K. Sandfeld ◽  
Nancy D. Dalton ◽  
Anthony D. Rangel ◽  
...  

Thorax ◽  
2013 ◽  
Vol 68 (Suppl 3) ◽  
pp. A133.2-A134
Author(s):  
M Fisk ◽  
N Gale ◽  
D Mohan ◽  
MN Marchong ◽  
J Forman ◽  
...  

2020 ◽  
Vol 39 (10) ◽  
pp. 3056-3065 ◽  
Author(s):  
Mariëlle P.K.J. Engelen ◽  
Renate Jonker ◽  
John J. Thaden ◽  
Gabriella A.M. Ten Have ◽  
Moon Sun Jeon ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document